Byrne Asset Management »

Arcutis Biotherapeutics shares owned by Byrne Asset Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Byrne Asset Management from 13F filings

Historical chart of Byrne Asset Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Byrne Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Byrne Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $991 100 9.91
2023-12-31 $302 100 3.02
2023-09-30 $1.0k 100 10.00
2023-06-30 $1.0k 100 10.00
2023-03-31 $2.0k 200 10.00
2022-12-31 $3.0k 200 14.80
2022-09-30 $4.0k 200 20.00
2022-06-30 $4.0k 200 20.00
2022-03-31 $4.0k 200 20.00
2021-12-31 $1.0k 50 20.00